These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [What do the phlebologist and the subject suffering from phlebologic disease think about a new therapeutic agent. Treatment of venous and microcirculatory stasis using Daflon. Apropos of 76 cases]. Itailau R. Phlebologie; 1974; 27(3):375-9. PubMed ID: 4445267 [No Abstract] [Full Text] [Related]
4. [Clinical evaluation of a new drug in phlebology]. Spartera C, Santoro P, Frezzotti A, Marciani A, Ricci G. Clin Ter; 1979 Jan 31; 88(2):139-47. PubMed ID: 428194 [No Abstract] [Full Text] [Related]
5. [Clinical experiences with a vasoprotective drug in the treatment of venous problems of the lower limbs]. De Caprio M, Vinci L, Giumetti D, Colitta G. Clin Ter; 1982 Jun 15; 101(5):497-508. PubMed ID: 6897029 [No Abstract] [Full Text] [Related]
7. At the crossroads of venous insufficiency and hemorrhoidal disease: Daflon 500 mg--repercussions of venous insufficiency on everyday life. Launois R. Angiology; 1994 Jun 15; 45(6 Pt 2):495-504. PubMed ID: 8203779 [Abstract] [Full Text] [Related]
16. [Therapy of effects of chronic venous insufficiency]. Müller KH. Z Allgemeinmed; 1971 Jul 10; 47(19):1012-3. PubMed ID: 5566297 [No Abstract] [Full Text] [Related]
17. [Value of Ercevit P in dermatology]. Bonnet J, Calas E, Florens A, Vallette P, Rebouillon P. Mars Med; 1969 Jul 10; 106(3):273-6. PubMed ID: 5397357 [No Abstract] [Full Text] [Related]
20. The role of Daflon in the treatment of acute hemorrhoids. Panijayanond P, Chotiprasidhi P. J Med Assoc Thai; 1985 Feb 10; 68(2):72-80. PubMed ID: 4009089 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]